Numbers and rates* of deaths with hepatitis B listed as a cause of death† among residents, by demographic characteristics — United States, 2018–2022
Characteristics | 2018 No. | 2018 Rate* (95% CI) |
2019 No. | 2019 Rate* (95% CI) |
2020 No. | 2020 Rate* (95% CI) |
2021 No. | 2021 Rate* (95% CI) |
2022 No. | 2022 Rate* (95% CI) |
---|---|---|---|---|---|---|---|---|---|---|
Total | 1,649 | 0.43 (0.41–0.45) |
1,662 | 0.42 (0.40–0.44) |
1,752 | 0.45 (0.42–0.47) |
1,748 | 0.44 (0.42–0.46) |
1797 | 0.44 (0.42–0.46) |
Age (years) | ||||||||||
0–34 | 32 | 0.02 (0.01–0.03) |
45 | 0.03 (0.02–0.04) |
36 | 0.02 (0.02–0.03) |
30 | 0.02 (0.01–0.03) |
32 | 0.02 (0.01–0.03) |
35–44 | 122 | 0.30 (0.24–0.35) |
110 | 0.26 (0.21–0.31) |
109 | 0.26 (0.21–0.31) |
123 | 0.28 (0.23–0.33) |
97 | 0.22 (0.18–0.27) |
45–54 | 283 | 0.68 (0.60–0.76) |
255 | 0.62 (0.55–0.70) |
269 | 0.67 (0.59–0.75) |
265 | 0.65 (0.57–0.73) |
256 | 0.63 (0.55–0.71) |
55–64 | 520 | 1.23 (1.12–1.34) |
502 | 1.18 (1.08–1.29) |
483 | 1.14 (1.04–1.24) |
486 | 1.14 (1.03–1.24) |
503 | 1.18 (1.07–1.28) |
65–74 | 422 | 1.38 (1.25–1.52) |
484 | 1.54 (1.40–1.67) |
495 | 1.52 (1.39–1.65) |
513 | 1.52 (1.39–1.66) |
536 | 1.59 (1.46–1.73) |
≥75 | 270 | 1.23 (1.08–1.38) |
266 | 1.18 (1.04–1.32) |
360 | 1.56 (1.40–1.72) |
331 | 1.49 (1.33–1.65) |
373 | 1.68 (1.51–1.85) |
Sex | ||||||||||
Male | 1,191 | 0.65 (0.61–0.69) |
1,248 | 0.66 (0.62–0.70) |
1,278 | 0.66 (0.63–0.70) |
1,260 | 0.65 (0.61–0.68) |
1,283 | 0.66 (0.62–0.69) |
Female | 458 | 0.22 (0.20–0.24) |
414 | 0.21 (0.19–0.24) |
474 | 0.22 (0.20–0.24) |
488 | 0.22 (0.20–0.24) |
514 | 0.22 (0.20–0.24) |
Race/ethnicity | ||||||||||
White, non-Hispanic | 754 | 0.27 (0.25–0.29) |
757 | 0.28 (0.26–0.30) |
739 | 0.27 (0.25–0.29) |
702 | 0.26 (0.24–0.28) |
778 | 0.27 (0.25–0.29) |
Black, non-Hispanic | 303 | 0.72 (0.63–0.80) |
290 | 0.67 (0.59–0.75) |
307 | 0.69 (0.61–0.77) |
306 | 0.66 (0.59–0.74) |
319 | 0.70 (0.62–0.78) |
Hispanic | 122 | 0.28 (0.23–0.33) |
117 | 0.27 (0.21–0.32) |
132 | 0.28 (0.23–0.33) |
136 | 0.28 (0.23–0.32) |
152 | 0.31 (0.26–0.36) |
Asian/Pacific Islander, non-Hispanic | 434 | 2.14 (1.94–2.35) |
457 | 2.13 (1.92–2.32) |
537 | 2.51 (2.30–2.73) |
564 | 2.54 (2.33–2.76) |
509 | 2.30 (2.10–2.50) |
Asian, non-Hispanic | 417 | 2.13 (1.92–2.32) |
439 | 2.12 (1.92–2.32) |
514 | 2.48 (2.26–2.70) |
528 | 2.43 (2.22–2.64) |
477 | 2.22 (2.02–2.42) |
Native Hawaiian or Other Pacific Islander, non-Hispanic | 17 | UR | 18 | UR | 23 | 3.89 (2.44–.89) |
36 | 5.95 (4.12–8.31) |
32 | 5.19 (3.50–7.41) |
American Indian/Alaska Native, non-Hispanic | S | UR | 16 | UR | 16 | UR | 16 | UR | 17 | UR |
Multiple race, non-Hispanic | 12 | UR | 15 | UR | 12 | UR | 14 | UR | 12 | UR |
HHS region: Regional office ¶ | ||||||||||
Region 1: Boston | 64 | 0.34 (0.26–0.45) |
43 | 0.22 (0.16–0.30) |
49 | 0.24 (0.18–0.33) |
58 | 0.28 (0.21–0.37) |
47 | 0.24 (0.17–0.32) |
Region 2: New York | 156 | 0.44 (0.36–0.51) |
147 | 0.42 (0.35–0.49) |
154 | 0.43 (0.36–0.50) |
149 | 0.41 (0.34–0.48) |
164 | 0.44 (0.37–0.51) |
Region 3: Philadelphia | 130 | 0.35 (0.29–0.41) |
126 | 0.32 (0.26–0.38) |
135 | 0.35 (0.29–0.41) |
130 | 0.34 (0.28–0.40) |
152 | 0.37 (0.31–0.43) |
Region 4: Atlanta | 346 | 0.45 (0.40–0.50) |
348 | 0.42 (0.38–0.47) |
352 | 0.43 (0.39–0.48) |
338 | 0.42 (0.37–0.47) |
357 | 0.43 (0.39–0.48) |
Region 5: Chicago | 174 | 0.28 (0.24–0.33) |
173 | 0.27 (0.23–0.31) |
212 | 0.33 (0.29–0.38) |
217 | 0.33 (0.28–0.37) |
204 | 0.32 (0.27–0.36) |
Region 6: Dallas | 230 | 0.47 (0.41–0.53) |
230 | 0.48 (0.42–0.55) |
229 | 0.47 (0.40–0.53) |
261 | 0.53 (0.46–0.59) |
229 | 0.47 (0.41–0.53) |
Region 7: Kansas City | 65 | 0.38 (0.29–0.48) |
51 | 0.30 (0.22–0.40) |
51 | 0.32 (0.23–0.42) |
35 | 0.21 (0.15–0.30) |
60 | 0.34 (0.25–0.44) |
Region 8: Denver | 34 | 0.25 (0.17–0.35) |
47 | 0.32 (0.23–0.43) |
54 | 0.41 (0.31–0.54) |
48 | 0.34 (0.25–0.45) |
45 | 0.33 (0.24–0.45) |
Region 9: San Francisco | 369 | 0.62 (0.56–0.69) |
394 | 0.64 (0.57–0.70) |
411 | 0.66 (0.59–0.72) |
408 | 0.68 (0.61–0.74) |
414 | 0.66 (0.60–0.73) |
Region 10: Seattle | 81 | 0.47 (0.37–0.59) |
103 | 0.58 (0.47–0.70) |
105 | 0.60 (0.48–0.72) |
104 | 0.61 (0.49–0.73) |
125 | 0.71 (0.58–0.83) |
* Rates for race/ethnicity, sex, US Department of Health and Human Services region, and the overall total are age-adjusted per 100,000 US standard population during 2000 by using the following age group distribution (in years): <1, 1–4, 5–14, 15–24, 25–34, 35–44, 45–54, 55–64, 65–74, 75–84, and ≥85. For age-adjusted death rates, the age-specific death rate is rounded to one decimal place before proceeding to the next step in the calculation of age-adjusted death rates for NCHS Multiple Cause of Death on CDC WONDER. This rounding step might affect the precision of rates calculated for small numbers of deaths. Missing data are not included.
¶ US Department of Health and Human Services regions were categorized according to the grouping of states and US territories assigned under each of the 10 Health and Human Services regional offices. For the purposes of this report, regions with US territories (Regions 2 and 9) contain data from states only.
UR: Unreliable rate. Rates where death counts were less than 20 were not displayed because of the instability associated with those rates.
S: Suppressed. In order to prevent revealing information that may identify specific individuals, small data values are not available when the count falls below a ratio of the representative demographic population.
CI: Confidence interval.
This table summarizes the characteristics of hepatitis B-related deaths among residents in the United States. During 2022, a total of 1,797 hepatitis B-related deaths among US residents were reported in the Provisional US Multiple Cause of Death data from the National Center for Health Statistics, which corresponds to an age-adjusted death rate of 0.44 cases per 100,000 population.
The US age-adjusted death rates for hepatitis B have been relatively consistent during the five-year period from 2018–2022. In 2022, the mortality rate was highest among non-Hispanic Asian/Pacific Islander persons (2.30 deaths per 100,000 population), 8.5 times the rate among non-Hispanic White persons (0.27 deaths per 100,000 population). Due to changes in the type of race and ethnicity data available from the National Vital Statistics System (NVSS) (see Technical Notes), data for hepatitis B-related deaths are reported separately for non-Hispanic Asian persons with a rate of 2.22 deaths per 100,000 population, and for non-Hispanic Native Hawaiian or Other Pacific Islander persons with a rate of 5.19 deaths per 100,000 persons, 19 times the rate among non-Hispanic White persons. Variations of disease rates by race or ethnicity may reflect systemic cultural, behavioral, environmental, and social factors, including structural racism.
Hepatitis B-related mortality rates were also higher among persons aged 55 years and older, males, and in US Department of Health and Human Services Regions 9 (Arizona, California, Hawaii, and Nevada) and 10 (Alaska, Idaho, Oregon, and Washington).
- Figure 2.1. Number of reported cases and estimated infections of acute hepatitis B — United States, 2015–2022
- Figure 2.2. Rates of reported cases of acute hepatitis B, by state or jurisdiction — United States, 2021–2022
- Figure 2.3. Rates of reported cases of acute hepatitis B, by state or jurisdiction — United States, 2022
- Figure 2.4. Rates of reported cases of acute hepatitis B, by age group — United States, 2007–2022
- Figure 2.5. Rates of reported cases of acute hepatitis B, by sex — United States, 2007–2022
- Figure 2.6. Rates of reported cases of acute hepatitis B, by race/ethnicity — United States, 2007–2022
- Figure 2.7. Availability of information on risk behaviors or exposures associated with reported cases of acute hepatitis B — United States, 2022
- Figure 2.8. Rates of deaths with hepatitis B listed as a cause of death among residents, by state or jurisdiction — United States, 2022
- Table 2.1. Numbers and rates of reported cases of acute hepatitis B, by state or jurisdiction — United States, 2018–2022
- Table 2.2. Numbers and rates of reported cases of acute hepatitis B, by demographic characteristics — United States, 2018–2022
- Table 2.3. Reported risk behaviors or exposures among reported cases of acute hepatitis B — United States, 2022
- Table 2.4. Number of newly reported cases of perinatal hepatitis B, by state or jurisdiction — United States, 2022
- Table 2.5. Number and rate of newly reported cases of chronic hepatitis B, by state or jurisdiction — United States, 2022
- Table 2.6. Number and rate of newly reported cases of chronic hepatitis B, by demographic characteristics — United States, 2022
- Table 2.7. Numbers and rates of deaths with hepatitis B listed as a cause of death among residents, by state or jurisdiction — United States, 2018–2022
- Table 2.8. Numbers and rates of deaths with hepatitis B listed as a cause of death among residents, by demographic characteristics — United States, 2018–2022